Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...
In a response to the US SEC decision Sanofi neither admitted nor denied any wrongdoing, but confirmed it will pay $25.2 million and agreed to a two-year period of self-reporting on effectiveness ...
The Manila Times on MSN20h
QC court schedules Dengvaxia hearing
A QUEZON City Regional Trial Court (QC-RTC) judge has set a schedule for the hearing of Dengvaxia cases following a Supreme ...
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,624.35 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...